BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32887218)

  • 1. In Silico Analyses and Cytotoxicity Study of Asiaticoside and Asiatic Acid from Malaysian Plant as Potential mTOR Inhibitors.
    Zulkipli NN; Zakaria R; Long I; Abdullah SF; Muhammad EF; Wahab HA; Sasongko TH
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32887218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-silico and in-vitro screening of Asiatic acid and Asiaticoside A against Cathepsin S enzyme.
    Ajani TA; Obikeze K; Magwebu ZE; Egieyeh S; Chauke CG
    BMC Pharmacol Toxicol; 2023 Nov; 24(1):67. PubMed ID: 38007481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining In Silico and In Vitro Studies to Evaluate the Acetylcholinesterase Inhibitory Profile of Different Accessions and the Biomarker Triterpenes of
    Jusril NA; Muhamad Juhari ANN; Abu Bakar SI; Md Saad WM; Adenan MI
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32721993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asiatic acid exerts anticancer potential in human ovarian cancer cells via suppression of PI3K/Akt/mTOR signalling.
    Ren L; Cao QX; Zhai FR; Yang SQ; Zhang HX
    Pharm Biol; 2016 Nov; 54(11):2377-2382. PubMed ID: 26984021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Protective Effects of Centella asiatica and Its Triterpenes: A Review.
    Razali NNM; Ng CT; Fong LY
    Planta Med; 2019 Nov; 85(16):1203-1215. PubMed ID: 31539918
    [No Abstract]   [Full Text] [Related]  

  • 6. Biomarker triterpenoids of Centella asiatica as potential antidepressant agents: Combining in vivo and in silico studies.
    Mando Z; Mando H; Afzan A; Shaari K; Hassan Z; Mohamad Taib MNA; Zakaria F
    Behav Brain Res; 2024 May; 466():114976. PubMed ID: 38599249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based grafting and identification of kinase-inhibitors to target mTOR signaling pathway as potential therapeutics for glioblastoma.
    Cui YH; Chen J; Xu T; Tian HL
    Comput Biol Chem; 2015 Feb; 54():57-65. PubMed ID: 25625417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
    Chaube U; Bhatt H
    Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro modulatory effects on three major human cytochrome P450 enzymes by multiple active constituents and extracts of Centella asiatica.
    Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Pook PC; Er HM; Ong CE
    J Ethnopharmacol; 2010 Jul; 130(2):275-83. PubMed ID: 20457244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential natural mTOR inhibitors screened by in silico approach and suppress hepatic stellate cells activation.
    Thiyagarajan V; Lee KW; Leong MK; Weng CF
    J Biomol Struct Dyn; 2018 Dec; 36(16):4220-4234. PubMed ID: 29183268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines.
    Leung EY; Askarian-Amiri M; Finlay GJ; Rewcastle GW; Baguley BC
    PLoS One; 2015; 10(7):e0131400. PubMed ID: 26148118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules.
    Vittorio S; Gitto R; Adornato I; Russo E; De Luca L
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33669763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centella asiatica in dermatology: an overview.
    Bylka W; Znajdek-Awiżeń P; Studzińska-Sroka E; Dańczak-Pazdrowska A; Brzezińska M
    Phytother Res; 2014 Aug; 28(8):1117-24. PubMed ID: 24399761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in silico protocol for identifying mTOR inhibitors from natural products.
    Chen L; Wang L; Gu Q; Xu J
    Mol Divers; 2014 Nov; 18(4):841-52. PubMed ID: 25156384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovering new mTOR inhibitors for cancer treatment through virtual screening methods and in vitro assays.
    Wang L; Chen L; Yu M; Xu LH; Cheng B; Lin YS; Gu Q; He XH; Xu J
    Sci Rep; 2016 Jan; 6():18987. PubMed ID: 26732172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotrophic Effect of Asiatic acid, a Triterpene of Centella asiatica Against Chronic 1-Methyl 4-Phenyl 1, 2, 3, 6-Tetrahydropyridine Hydrochloride/Probenecid Mouse Model of Parkinson's disease: The Role of MAPK, PI3K-Akt-GSK3β and mTOR Signalling Pathways.
    Nataraj J; Manivasagam T; Justin Thenmozhi A; Essa MM
    Neurochem Res; 2017 May; 42(5):1354-1365. PubMed ID: 28181071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-Brain Barrier Permeability of Asiaticoside, Madecassoside and Asiatic Acid in Porcine Brain Endothelial Cell Model.
    Hanapi NA; Mohamad Arshad AS; Abdullah JM; Tengku Muhammad TS; Yusof SR
    J Pharm Sci; 2021 Feb; 110(2):698-706. PubMed ID: 32949562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cancer activity of asiatic acid against human cholangiocarcinoma cells through inhibition of proliferation and induction of apoptosis.
    Sakonsinsiri C; Kaewlert W; Armartmuntree N; Thanan R; Pakdeechote P
    Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):28-33. PubMed ID: 30084792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of major centelloside ratios in Centella asiatica accessions grown under identical ecological conditions, bioconversion clues and identification of elite lines.
    Kunjumon R; Johnson AJ; Sukumaryamma Remadevi RK; Baby S
    Sci Rep; 2022 May; 12(1):8177. PubMed ID: 35581314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.
    MacKeigan JP; Krueger DA
    Neuro Oncol; 2015 Dec; 17(12):1550-9. PubMed ID: 26289591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.